22 December 2020 in The EMBO Journal
MRNA transport in neurons requires formation of transport granules containing many protein components, and subsequent alterations in phosphorylation status can release transcripts for translation. Further, mutations in a structurally disordered domain of the transport granule protein hnRNPA2 increase its aggregation and cause hereditary proteinopathy of neurons, myocytes, and bone. We examine in vitro hnRNPA2 granule component phase separation, partitioning specificity, assembly/disassembly, and the link to neurodegeneration. Transport granule components hnRNPF and ch‐TOG interact weakly with hnRNPA2 yet partition specifically into liquid phase droplets with the low complexity domain (LC) of hnRNPA2, but not FUS LC. In vitro hnRNPA2 tyrosine phosphorylation reduces hnRNPA2 phase separation, prevents partitioning of hnRNPF and ch‐TOG into hnRNPA2 LC droplets, and decreases aggregation of hnRNPA2 disease variants. The expression of chimeric hnRNPA2 D290V in Caenorhabditis elegans results in stress‐induced glutamatergic neurodegeneration; this neurodegeneration is rescued by loss of tdp‐1, suggesting gain‐of‐function toxicity. The expression of Fyn, a tyrosine kinase that phosphorylates hnRNPA2, reduces neurodegeneration associated with chimeric hnRNPA2 D290V. These data suggest a model where phosphorylation alters LC interaction specificity, aggregation, and toxicity.
12 May 2021 in Nature Communications
High-throughput splicing assays have demonstrated that many exonic variants can disrupt splicing; however, splice-disrupting variants distribute non-uniformly across genes. We propose the existence of exons that are particularly susceptible to splice-disrupting variants, which we refer to as hotspot exons. Hotspot exons are also more susceptible to splicing perturbation through drug treatment and knock-down of RNA-binding proteins. We develop a classifier for exonic splice-disrupting variants and use it to infer hotspot exons. We estimate that 1400 exons in the human genome are hotspots. Using panels of splicing reporters, we demonstrate how the ability of an exon to tolerate a mutation is inversely proportional to the strength of its neighboring splice sites.
5 September 2025 in Computers in Biology and Medicine
The fifth edition of the WHO classification of brain tumors increasingly emphasizes the role of extensive genetic testing in the diagnosis of gliomas. In this context, computational pathology foundation models (FMs) present a promising approach for inferring molecular entities directly from conventional, H&E-stained histological images, potentially reducing the need for genetic analysis. We conducted a robust investigation into the ability of five established FMs to generate effective embeddings for downstream glioma classification using three datasets (TCGA, n=839 samples; EBRAINS, n=786 samples; TUM, n=250 samples) and state-of-the-art augmentation techniques. Our results demonstrate that FM embeddings enable competitive glioma classification performance, even with limited training data, achieving one-vs-rest AUC>0.93 on all three datasets. However, we observed substantial differences between FMs in their downstream performance, susceptibility to perturbations, and consistency across multiple datasets. Dataset diversity and content of central nervous tissue were associated with improved generalization, while model and dataset size were not. Common to all FMs was a propensity to capture dataset-specific features in their embeddings. We examined Macenko normalization and random convolutions as potential solutions to combat dataset-dominated embeddings and show that ensembling FM embeddings over multiple augmented views improves downstream classifier performance. In summary, our findings highlight both the promise and current limitations of computational pathology foundation models for glioma classification, emphasizing the critical roles of training data composition and downstream augmentation to achieve strong task performance.